Clinical Trial Update: Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus [Phase 3]

View source ↗

Summary

Phase 3 study assessing immunogenicity non-inferiority, safety, and lot-to-lot consistency of Biovac OCV-S versus Euvichol-Plus for cholera vaccination; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Biovac OCV-S
• Euvichol-Plus

Snippet

Sponsor: International Vaccine Institute | Conditions: Cholera Vaccination | Phase 3 | Status: RECRUITING